RELENZA
RELENZA
Approved
DIN Number
02240863
Drug Class
Human
Market Date
Dec 7, 1999
Company
HC
GlaxoSmithKline Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02240863
AIG Number0138401001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J05AH01 ZANAMIVIR
Product Specifications
Dosage FormPowder
Route of AdministrationOral
,
Inhalation
AHFS Classification08:18.28
Health Canada Classification
ACTIVE INGREDIENTS (1)
ZANAMIVIRActive
Strength: 5 MG / ACT
Monograph: ZANAMIVIR